200,000+ products from a single source!

sales@angenechem.com

Home > Nitro Compounds > 131549-85-4

131549-85-4

131549-85-4 | Benzenesulfonamide, N-(5-methyl-3-isoxazolyl)-4-nitroso-

CAS No: 131549-85-4 Catalog No: AG000ZEM MDL No:

Product Description

Catalog Number:
AG000ZEM
Chemical Name:
Benzenesulfonamide, N-(5-methyl-3-isoxazolyl)-4-nitroso-
CAS Number:
131549-85-4
Molecular Formula:
C10H9N3O4S
Molecular Weight:
267.2612
IUPAC Name:
N-(5-methyl-1,2-oxazol-3-yl)-4-nitrosobenzenesulfonamide
InChI:
InChI=1S/C10H9N3O4S/c1-7-6-10(12-17-7)13-18(15,16)9-4-2-8(11-14)3-5-9/h2-6H,1H3,(H,12,13)
InChI Key:
GHNQGDUYHCZZPT-UHFFFAOYSA-N
SMILES:
O=Nc1ccc(cc1)S(=O)(=O)Nc1noc(c1)C

Properties

Complexity:
386  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
267.031g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
267.259g/mol
Monoisotopic Mass:
267.031g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
110A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.9  

Literature

Title Journal
Characterization of Drug-Specific Signaling Between Primary Human Hepatocytes and Immune Cells. Toxicological sciences : an official journal of the Society of Toxicology 20170701
Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase. Chemical research in toxicology 20150120
The development of in vitro culture methods to characterize primary T-cell responses to drugs. Toxicological sciences : an official journal of the Society of Toxicology 20120501
Covalent binding of nitroso-sulfonamides to glutathione S-transferase in guinea pigs with delayed type hypersensitivity. International immunopharmacology 20120401
Cutaneous drug hypersensitivity: immunological and genetic perspective. Indian journal of dermatology 20110101
Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism. Journal of immunology (Baltimore, Md. : 1950) 20101201
Stimulation of human T cells with sulfonamides and sulfonamide metabolites. The Journal of allergy and clinical immunology 20100201
Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo. Molecular pharmacology 20080601
Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. Journal of immunology (Baltimore, Md. : 1950) 20070501
Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso. Toxicology 20060501
Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study. Toxicology 20050301
Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells. Toxicology 20050115
Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. British journal of pharmacology 20010501
Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells. British journal of pharmacology 20010201
Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. Journal of immunology (Baltimore, Md. : 1950) 20000615
Fine structural specificity differences of trimethoprim allergenic determinants. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 19961001

© 2019 Angene International Limited. All rights Reserved.